Coherus Oncology (CHRS) Selling, General & Administrative (2013 - 2026)
Coherus Oncology (CHRS) posted Selling, General & Administrative of $20.95 million for Q2 2026, down 19.5% from $26.04 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Selling, General & Administrative (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Coherus Oncology was $92.6 million, down 15.7% year-over-year; for FY2025, it came in at $100.6 million, down 19.8% from FY2024.
- Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
- In prior years, Coherus Oncology's Selling, General & Administrative was $125.48 million in FY2024 (-34.6%), $192.02 million in FY2023 (-3.3%), $198.48 million in FY2022 (+17.0%) and $169.71 million in FY2021 (+22.0%).
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q2 2018.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last 11 quarters, with an average decline of 23.1% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 32.8%; the weakest was Q3 2024, with a decline of 41.7%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $23.1 million (Q1 2026), $23.61 million (Q4 2025) and $24.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 20.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.95 Mn |
| Mar 31, 2026 | 23.10 Mn |
| Dec 31, 2025 | 23.61 Mn |
| Sep 30, 2025 | 24.93 Mn |
| Jun 30, 2025 | 26.04 Mn |
| Mar 31, 2025 | 26.03 Mn |
| Dec 31, 2024 | 29.61 Mn |
| Sep 30, 2024 | 28.13 Mn |
| Jun 30, 2024 | 27.52 Mn |
| Mar 31, 2024 | 40.23 Mn |
| Dec 31, 2023 | 49.49 Mn |
| Sep 30, 2023 | 48.22 Mn |
| Jun 30, 2023 | 45.14 Mn |
| Mar 31, 2023 | 49.15 Mn |
| Dec 31, 2022 | 53.62 Mn |
| Sep 30, 2022 | 44.83 Mn |
| Jun 30, 2022 | 51.28 Mn |
| Mar 31, 2022 | 48.75 Mn |
| Dec 31, 2021 | 50.05 Mn |
| Sep 30, 2021 | 39.93 Mn |
API Access
Coherus Oncology Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();